18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain

Journal of Nuclear Medicine

Volumn 51, Issue 8, 2010, Pages 1301-1309

  Yui, Joji ^a   Maeda, Jun ^a   Kumata, Katsushi ^a   Kawamura, Kazunori ^a   Yanamoto, Kazuhiko ^a   Hatori, Akiko ^a   Yamasaki, Tomoteru ^a   Nengaki, Nobuki ^a,b   Higuchi, Makoto ^a   Zhang, Ming Rong ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b 141 0032   (Japan)

Author keywords

18F FEAC; 18F FEDAC; Infarction; Ischemia; Translocator protein (18 kDa)

Indexed keywords

CARRIER PROTEIN; N BENZYL N ETHYL 2 [7,8 DIHYDRO 7 (2 FLUOROETHYL) 8 OXO 2 PHENYL 9H PURIN 9 YL]ACETAMIDE F 18; N BENZYL N METHYL 2 [7,8 DIHYDRO 7 (2 FLUOROETHYL) 8 OXO 2 PHENYL 9H PURIN 9 YL]ACETAMIDE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FLUORINE; ISOQUINOLINE DERIVATIVE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN HOMOGENATE; BRAIN INFARCTION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SYNTHESIS; DRUG TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RAT; ANIMAL; BIOTRANSFORMATION; BRAIN; MACACA; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTORADIOGRAPHY; BIOTRANSFORMATION; BRAIN; CEREBRAL INFARCTION; FLUORINE RADIOISOTOPES; ISOQUINOLINES; MACACA MULATTA; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; TISSUE DISTRIBUTION;

EID: 77956208191     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.072223     Document Type: Article

References (27)

1. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402-409. (Pubitemid 44069585)
2. Braestrup C, Albrechtsen R, Squires RF. High densities of benzodiazepine receptors in human cortical areas. Nature. 1977;269:702-704.
3. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629-650.
4. Maeda J, Higuchi M, Inaji M, et al. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007;1157:100-111.
5. 11C] PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab. 2007;27:1975-1986.
6. Chen MK, Guilarte TR. Translocator protein 18kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1-17.
7. Maeda J, Ji B, Irie T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci. 2007;27:10957-10968.
8. 11C]DAA1106. Biol Psychiatry. 2008;64:835-841.
9. Ji B, Maeda J, Sawada M, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimers and other CNS pathologies. J Neurosci. 2008;28:12255-12267.
10. 11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35:2304-2319.
11. Dollé F, Luus C, Reynolds A, Kassiou M. Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. Curr Med Chem. 2009;16:2899-2923.
12. 11C-PBR-28: a PET ligand to image inflammation. J Nucl Med. 2007;48:2072-2079.
13. 18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem. 2008;51:3700-3712.
14. James ML, Fulton RR, Vercoullie J, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacological characterization. J Nucl Med. 2008;49:814-822.
15. 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med. 2009;50:468-476.
16. 18F-PBR06. J Nucl Med. 2009;50:1047-1053.
17. 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med. 2009;50:1276-1282.
18. 18F]DPA-714 in a rat model of focal cerebral ischemia. J Cereb Blood Flow Metab. 2010;30:230-241.
19. Pappata S, Cornu P, Samson Y, et al. PET study of carbon-11-PK11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med. 1991;32:1608-1610.
20. 11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse. 2004;52:283-291.
21. 11C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol. 2003;30:513-519.
22. 18F]fluoroethoxyl-5-methoxybenzyl) acetamide, for PET imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem. 2004;47:2228-2235.
23. 11C]AC-5216: a novel positron emission tomography ligand for peripheral-type benzodiazepine receptors in primate brain. J Nucl Med. 2007;48:1853-1861.
24. 11C]DAA1106. J Cereb Blood Flow Metab. 2007;27:173-184.
25. 18F]FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. J Nucl Med. 2006;47:43-50.
26. 11C-AC- 5216. J Nucl Med. 2009;50:1095-1101.
27. 18F]FEDAC: two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in brain. Bioorg Med Chem Lett. 2009;19:1707-1710.